Abstract
An overview of the intravenous treatment with antiplatelet inhibitors (GP IIb/IIIa), anticoagulants (heparin) and thrombolytic drugs (rhu-tPA, etc.). Described is also the indication and tha possibility of laboratory control treatment.
Included are newly tested synthetic intravenous antithrombotics such as aptamers anti-vWF, anti-thrombin and anti-FIXa